Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathies | 3 | 2022 | 517 | 1.000 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2022 | 19 | 0.730 |
Why?
|
| Calcium | 5 | 2024 | 1030 | 0.660 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2020 | 6 | 0.640 |
Why?
|
| Calcium Signaling | 5 | 2024 | 241 | 0.640 |
Why?
|
| Desmoplakins | 1 | 2020 | 12 | 0.640 |
Why?
|
| Ectodermal Dysplasia | 1 | 2020 | 48 | 0.610 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 675 | 0.530 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 5 | 2024 | 241 | 0.460 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2024 | 484 | 0.430 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2024 | 148 | 0.420 |
Why?
|
| Myocardium | 4 | 2007 | 865 | 0.370 |
Why?
|
| Annexin A5 | 3 | 2008 | 18 | 0.360 |
Why?
|
| Ankyrins | 1 | 2012 | 96 | 0.340 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2012 | 22 | 0.330 |
Why?
|
| Caveolin 3 | 2 | 2005 | 6 | 0.250 |
Why?
|
| Mutation | 2 | 2020 | 6148 | 0.250 |
Why?
|
| Annexins | 1 | 2005 | 2 | 0.230 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2018 | 79 | 0.210 |
Why?
|
| Isoproterenol | 2 | 2024 | 87 | 0.200 |
Why?
|
| Plakophilins | 1 | 2022 | 4 | 0.190 |
Why?
|
| Troponin I | 1 | 2022 | 122 | 0.170 |
Why?
|
| Actins | 1 | 2022 | 315 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 159 | 0.160 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 272 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2020 | 362 | 0.150 |
Why?
|
| Serine | 1 | 2018 | 161 | 0.140 |
Why?
|
| Mice | 6 | 2024 | 18287 | 0.120 |
Why?
|
| Pedigree | 1 | 2020 | 1684 | 0.120 |
Why?
|
| Animals | 10 | 2024 | 34025 | 0.120 |
Why?
|
| Nitric Oxide Synthase | 2 | 2007 | 168 | 0.120 |
Why?
|
| Heart Failure | 2 | 2005 | 2322 | 0.110 |
Why?
|
| Sodium | 1 | 2016 | 279 | 0.110 |
Why?
|
| Aging | 1 | 2022 | 1255 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 255 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2007 | 468 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4683 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2010 | 1014 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 65 | 0.090 |
Why?
|
| Diastole | 1 | 2012 | 178 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2024 | 1575 | 0.080 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2010 | 20 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 66 | 0.080 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2010 | 71 | 0.080 |
Why?
|
| Calcium Phosphates | 1 | 2008 | 19 | 0.070 |
Why?
|
| Chondrocytes | 1 | 2008 | 49 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 45 | 0.070 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 64 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3839 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 245 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 199 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 34 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2005 | 54 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 190 | 0.060 |
Why?
|
| Humans | 7 | 2022 | 130980 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 194 | 0.050 |
Why?
|
| Reference Values | 1 | 2005 | 680 | 0.050 |
Why?
|
| Infant | 1 | 2020 | 13332 | 0.050 |
Why?
|
| Apoptosis | 2 | 2008 | 1852 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4716 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2004 | 202 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2018 | 2911 | 0.040 |
Why?
|
| Male | 4 | 2024 | 64783 | 0.040 |
Why?
|
| Excitation Contraction Coupling | 1 | 2018 | 14 | 0.040 |
Why?
|
| Rats | 3 | 2010 | 3426 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 340 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2008 | 127 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2007 | 303 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2016 | 165 | 0.030 |
Why?
|
| Female | 1 | 2020 | 70723 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2010 | 13 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 61 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 296 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 228 | 0.020 |
Why?
|
| Sirolimus | 1 | 2010 | 229 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1088 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 55 | 0.020 |
Why?
|
| Crystallization | 1 | 2008 | 83 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2007 | 18 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 143 | 0.020 |
Why?
|
| Uric Acid | 1 | 2008 | 110 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 502 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 1189 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1659 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 642 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2010 | 771 | 0.010 |
Why?
|
| Staurosporine | 1 | 2004 | 23 | 0.010 |
Why?
|
| Sarcolemma | 1 | 2004 | 13 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 51 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 119 | 0.010 |
Why?
|
| Caveolins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 112 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2004 | 28 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 116 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2004 | 39 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 157 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 90 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 568 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1137 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1216 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 982 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 28555 | 0.000 |
Why?
|